Optiscan Imaging Ltd has released a press release.
Collaboration Agreement with Summit Biomedical Imaging LLC
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- OptiScan technology used in research at major cancer centre
- Reinstatement to Official Quotation
- ZEISS achieves another milestone on regulatory pathway
- Suspension from Official Quotation
- Clinical Trial - Assessment of Breast Cancer Margin
Later from Optiscan Imaging
- Appendix 4D and Financial Statements - 31 Dec 2018
- OptiScan March 2019 Presentation
- Optiscan Secures Strong Support in $1.70 M Capital Raising
- Investor Presentation - June 2019
- Optiscan System Approved for Prestigious Cancer Centre Trial
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging